← Back

$ Value

$0

Shares

946,107

Price

$0

Filed

Apr 7

Insider

Name

Bagai Shaun

Title

Chief Executive Officer

CIK

0001862613

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

946,107

Footnotes

On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 946,107 shares of the Issuer's common stock (111,621 shares of which are underlying incentive stock options and 834,486 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.

Filing Info

Accession No.

0001493152-26-015594

Form Type

4

Issuer CIK

0001574094

Bagai Shaun's History

Date Ticker Type Value
2026-04-03 RNXT A $0
2026-03-20 RNXT
2026-03-20 RNXT
2025-12-18 RNXT $5K
2025-12-17 RNXT $4K
2025-08-25 RNXT $5K
2025-08-22 RNXT $5K
2025-07-01 RNXT A $0

Other Insiders at RNXT (90d)

Insider Bought Sold Last
VOLL MARK
Chief Financial Officer
2026-04-03
Marton Laurence 2026-03-20
Bagai Shaun
Chief Executive Officer
2026-03-20
Agah Ramtin
Chief Medical Officer
2026-04-03
Gentry Leesa
Chief Clinical Officer
2026-04-03